LPCN CIK: 1535955

Lipocine Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.48
FY22:
−8.06
FY23:
−13.0
FY24:
3.85
FY25:
−6.61
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.52
FY22:
−20.7
FY23:
−28.1
FY24:
−8.51
FY25:
−19.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.21
FY22:
−11.5
FY23:
−16.5
FY24:
−1.13
FY25:
−10.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.63
FY22:
−10.8
FY23:
−16.4
FY24:
0.01
FY25:
−9.63
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.63
FY22:
−10.8
FY23:
−16.4
FY24:
0.01
FY25:
−9.63

All amounts in millions USD Data sources:SEC EDGARTwelve Data